Transfusion services Single Source Justification_Redacted.pdf

PDF 185 KB Posted

Attached to
Q702--Auto-Transfusion Services (CellSavers) Federal contract opportunity
Solicitation number
36C25623N0083
Issued by
Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16

View the file

Other files for this federal contract opportunity

Other files attached to Q702--Auto-Transfusion Services (CellSavers), newest first.
File Type Posted
36C25621D0013-36C25623N0083.docx DOCX document

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Last Updated: 02/01/22 Page 1 of 1

DEPARTMENT OF VETERANS AFFAIRS

Justification for Single Source Awards IAW FAR 13.106-1 For

Over Micro-Purchase Threshold but Not Exceeding the SAT ($250K)

Acquisition Plan Action ID: 36C256-22-AP-4968

1. Contracting Activity: Department of Veterans Affairs, Network Contracting Office 16 (NCO 16), 5075 Westheimer Road, Suite 750, Houston, TX 77056.

Organization Activity: Department of Veterans Affairs, VISN 16, Central Arkansas Veterans HealthCare System (CAVHS), 4300 West 7th Street, Little Rock, Arkansas 72205.

2237 number 598-23-1-094-0001.

2. Brief Description of Supplies/ Services required and the intended use/Estimated Amount:

Autologous Transfusions Systems to be used before, during and after surgery for the purpose of salvaging the patient's own blood. The estimated amount of this requirement is

3. Unique characteristics that limit availability to only one source, with the reason no other supplies or services can be used:

The current contractor providing Autologous Transfusions blood recovery services is a small business whose provider is currently privileged at the medical facility and poised to perform the emergent surgical cases without delay or interruption. To procure new Autologous Transfusions blood recovery services would delay the emergent surgical cases and increase adverse patient outcomes.

4. Description of market research conducted and results or statement why it was not conducted:

The current contract (36C25621D0013) is an Indefinite Delivery Indefinite Quantity type contract set to expire March 31, 2023; however, an emergent need arose that required continued Autologous Transfusions blood recovery services until April 30, 2023.

It is recommended that this requirement be solicited from a single source for urgent Autologous Transfusions blood recovery services to perform for emergent surgical procuedures in accordance with FAR 13.106-1(b)(i) and FAR clause 52.216-22(d).

5. Contracting Officer's Certification: Purchase is approved in accordance with FAR13.106- 1(b)(i) for urgency. I certify that the foregoing justification is accurate and complete to the best of my knowledge and belief.

Troy Davis Date Contracting Officer

File details come from the government source that posted it. Updated .